ISSN# 1545-4428 | Published date: 19 April, 2024
You must be logged in to view entire program, abstracts, and syllabi
At-A-Glance Session Detail
   
Novel Techniques in Cancer
Digital Poster
Body
Monday, 06 May 2024
Exhibition Hall (Hall 403)
08:15 -  09:15
Session Number: D-48
No CME/CE Credit

Computer #
1466.
65Quantitative assessment of breast tumor: comparison of different region of interest for synthetic relaxometry and diffusion measurement
Weibo Gao1, Quanxin Yang1, and Xiaocheng Wei2
1The Second Affiliated Hospital of Xi’an Jiaotong University, Xi 'an, China, 2GE HealthCare MR Research, Beijing, China

Keywords: fMRI Analysis, Breast

Motivation: The lack of guidelines or recommendations for the ROI size of DWI and synthetic MRI.

Goal(s): To investigate the effect of different ROI positioning methods on both ADC and synthetic MRI measurements and to subsequently evaluate the diagnostic performance of differently shaped ROIs.

Approach: Four different ROI positioning methods on ADC and synthetic parameters measurements. 

Results: Square ROI showed the optimal AUC followed by freehand ROI. T2 + ADC were more diagnostic than ADC or T2 alone.

Impact: The different ROI positioning methods used had a significant impact on the quantitative measurements and the performance in differentiating benign from malignant breast tumors.

1467.
66Enhancing Breast Cancer Diagnosis through Deep Learning-Based DWI in Conjunction with Kaiser Score
Wanjun Xia1, Yong Zhang1, Kaiyu Wang2, and Jingliang Cheng1
1Department of Magnetic Resonance, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, 2MR Research China, GE Healthcare, Beijing, China

Keywords: Breast, Breast, diffusion magnetic resonance imaging; deep learning, Magnetic resonance imaging; kaiser score

Motivation: While the Kaiser score serves a pivotal role in diagnosing breast cancer, it still encounters scenarios where false positives necessitate biopsy confirmation.

Goal(s): This study aims to investigate approaches to enhance the diagnostic efficacy of the Kaiser score through MRI.

Approach: Leveraging deep learning to enhance both the quality of DWI images and diagnosis, we sought more effective indicators in conjunction with the Kaiser score.

Results: ADC values derived from DWI images reconstructed using deep learning, with a b-value of 800 s/mm², in tandem with the Kaiser score, significantly enhance the diagnostic performance nearing 1.

Impact: Integrating DWI under deep learning with the Kaiser score can elevate the accuracy of differentiating between benign and malignant breast cancers to almost 100%, leading to substantial improvements in breast cancer diagnosis and a reduction in unnecessary biopsies.

1468.
67Amide proton transfer weighted imaging and diffusion kurtosis imaging in differentiating breast lesions by comparing with BI-RADS
Yingying Ma1, Peng Wang 1, Lin Shao1, Yuxi Ge 1, Hongyan Qiao 1, Xiao Yang1, Weiqiang Dou2, and Shudong Hu 1
1Department of Radiology, Affiliated Hospital of Jiangnan University, Wuxi Medical School of Jiangnan University, Wuxi, Jiangsu, 214122, People’s Republic of China, Wuxi, China, 2GE Healthcare, MR Research China GE Healthcare, MR Research China, Beijing, P.R. China, Beijing, China

Keywords: fMRI Acquisition, Breast, Amide proton transfer weighted imaging, Diffusion kurtosis imaging

Motivation: Breast Imaging Reporting and Data System (BI-RADS) is an internationally recognized scoring standard for the diagnosis of breast lesions, but it is highly subjective.

Goal(s): To evaluate the diagnostic performance of amide proton transfer weighted imaging (APTWI) and diffusion kurtosis imaging (DKI) in terms of differentiating breast lesions and to compare them with the BI-RADS independently or jointly.

Approach: Prospective cohort study

Results:  APTWI and DKI can be used to distinguish  breast lesions. The combination with APTWI and DKI can significantly improve the AUC values and specificity when compared with BI-RADS alone. The APTWI+DKI+BI-RADS has the best diagnostic performance in distinguishing  breast lesions.

Impact: The combined APTWI and DKI outperformed BI-RADS alone in distinguishing benign and malignant breast lesions.

1469.
68Differentiation of breast cancer subtypes using amide proton transfer-weighted imaging and DWI: the correlation with biological status
Mingzhe Xu1, Xuejun Chen1, Dongqiu Dan1, and Zhiwei Shen2
1The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China, 2Philips healthcare, Beijing, China

Keywords: fMRI Analysis, Breast, Cancer

Motivation: APTWI and DWI had still some controversies between their parameters and some biological status.

Goal(s): To assess the value of amide proton transfer-weighted imaging (APTWI) and diffusion weighted imaging (DWI) in differentiating biological subtypes and predicting the biological status of breast tumors.

Approach: The Kruskal-Wallis H test and Post-hoc pairwise comparison, Pearson's correlation analysis. Independent samples t-test. Receiver operating characteristic (ROC) analysis.
 

Results: MTRasym (3.5 ppm) was higher in breast tumours that were TN, ER-, PR-, and high-Ki-67. Compared to DWI, APTWI is more useful in predicting the biological status of breast cancers.

Impact:  Compared to DWI, APTWI is more useful in predicting the biological status of breast cancers.

1470.
69Comparing DWI image quality of deep-learning-reconstructed EPI with RESOLVE in breast lesions at 3.0T: a pilot study
Marialena Tsarouchi1,2,3, Antonio Portaluri3,4, Marnix Maas1, and Ritse Mann1,3
1Radiology, Nuclear Medicine and Anatomy, Radboudumc, Nijmegen, Netherlands, 2Netherlands Cancer Institute, Amsterdam, Netherlands, 3Radiology, Netherlands Cancer Institute, Amsterdam, Netherlands, 4Biomedical Sciences and Functional Imaging, University of Messina, Messina, Italy

Keywords: Breast, Cancer

Motivation: DWI’s challenging spatial resolution could be addressed by deep-learning-based image reconstruction, by reducing noise without increasing acquisition time.

Goal(s): To compare the image quality of the Echo-Planar-Imaging-Deep-Learning (EPI-DL) DWI sequence with the clinically used simultaneous-multi-slice (SMS) RESOLVE in breast lesions.

Approach: EPI-DL and RESOLVE breast images from 20 participants were qualitatively evaluated ed. Quantitative image quality metrics of SNR and CNR on both high b-value (b800) images and ADC maps were calculated.

Results: SNR in RESOLVE vs. EP-DL differed statistically significantly in manually delineations for b800 (p=0.006), ADC maps (p=0.001), and in ADC circularly delineations (p=0.001).

Impact: DWI-DL reconstruction may be clinically useful for addressing low-spatial resolution without compromising acquisition time and image quality. Such benefits coupled with the available methods of readout segmentation and SMS acquisitions may further enhance the value of DWI in breast imaging.

1471.
70A pilot study on the value of T1ρ mapping in preoperatively predicting the status of ER, PR, HER-2 and Ki-67 in breast cancer
Lanqing Yang1, Sixian Hu1, Xiaoyong Zhang2, Xiaoxiao Zhang2, Zhigang Wu2, and Chunchao Xia1
1West China Hospital, Chengdu, China, 2Philips Healthcare, Chengdu, China

Keywords: Breast, Breast

Motivation: Noninvasive imaging methods capable of revealing molecular characteristic heterogeneity in breast cancer may help to compensate for the sampling errors of biopsy and guide tailored treatment.
  

Goal(s): To explore the value of T1ρ mapping in preoperatively predicting the status of ER, PR, HER-2 and Ki-67 in breast cancer.

Approach: This is a prospective diagnostic study. The differences of T1ρ values of tumors with different status of ER, PR, HER-2 and Ki-67 were compared between groups.

Results: The T1ρ values showed significant differences in ER (P<0.01), PR(P=0.01), HER-2 (P=0.04), and Ki-67(P=0.02) negative and positive groups, with respective AUCs of 0.867, 0.79, 0.77, and 0.75.

Impact: T1ρ mapping is expected to be a non-invasive tool to help evaluate ER, PR, HER-2, and Ki-67 status before surgery in breast cancer, and to provide assistance in individualized treatment.

1472.
71Fibroglandular tissue segmentation and background parenchymal enhancement quantification in breast MRI using an anatomy-aware loss function
Ran Yan1,2, Haoxin Zheng1,3, Alex Ling Yu Hung1,3, Tiffany Yu1, Stephanie Lee-Felker1, and Kyunghyun Sung1,2
1Department of Radiological Sciences, University of California, Los Angeles, Los Angeles, CA, United States, 2Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, United States, 3Department of Computer Science, University of California, Los Angeles, Los Angeles, CA, United States

Keywords: Segmentation, Machine Learning/Artificial Intelligence, Fibroglandular tissue; Background parenchymal enhancement; Breast cancer

Motivation: Fully automatic segmentation of fibroglandular tissue (FGT) and background parenchymal enhancement (BPE) quantification methods with high generalizability for different FGT levels are still lacking.

Goal(s): We aimed to improve the segmentation accuracy and generalizability across various FGT levels that accurately quantify FGT density and BPE.

Approach: A novel anatomy-aware loss function based on the variations in FGT level was applied in a fully automatic segmentation model training on breast MRIs.

Results: The accuracy of breast tissue segmentation, FGT density estimation, and BPE quantification were improved at various FGT levels.

Impact: The anatomy-aware loss function can help improve the generalization of the breast tissue segmentation model on patients with different breast densities, thereby enabling the model to be more widely used in fibroglandular tissue density estimation and background parenchymal enhancement quantification.

1473.
72CEST MR Fingerprinting for In Vivo Bilateral Breast Imaging
Jessica A. Martinez1, Elizabeth J. Sutton1, Ricardo Otazo1, and Ouri Cohen1
1Memorial Sloan Kettering Cancer Center, New York, NY, United States

Keywords: Breast, Breast, CEST, CEST-MRF, DRONE

Motivation: To enable quantitative CEST and MT maps in breast tissue for potential tumor characterization.

Goal(s): To explore the feasibility of simultaneously obtaining T1, T2, CEST and MT maps in breast tissue.

Approach: A CEST-MRF pulse sequence was used to measure the amide and semi-solid exchange rate and volume fractions. Quantitative maps were obtained using a neural network trained on physics-derived signals.

Results: The proposed approach yields water T1 and T2 relaxation maps, amide exchange and volume fraction maps, and semi-solid exchange and volume fraction maps in the breast in a scan time of less than 2 minutes.

Impact: Comprehensive quantitative T1, T2, amide CEST and MT bilateral breast imaging in under 2 minutes can improve the detection and characterization of breast cancer and the response to treatment in a clinical setting without the use of a contrast agent.

1474.
73The relationship of intracellular sodium fraction and pharmacokinetics in breast cancer
Joshua D Kaggie1, Otso Arponen1, Mary A McLean1, Muzna Nanaa1, Roido Manavaki1, Gabrielle C Baxter1, Andrew B Gill1, Jonathan Birchall1, Frank Riemer2, Aneurin Kennerley3,4, Ramona Woitek1, William J Brackenbury4,5, and Fiona J Gilbert1
1Radiology, University of Cambridge, Cambridge, United Kingdom, 2Mohn Medical Imaging and Visualization Centre (MMIV), Haukeland University Hospital, Bergen, Norway, 3Institute of Sport, Department of Sport and Exercise Science, Manchester Metropolitan University, Manchester, United Kingdom, 4Biology, University of York, York, United Kingdom, 5York Biomedical Research Institute, University of York, York, United Kingdom

Keywords: Breast, Cancer, sodium, breast, inversion recovery, DCE-MRI

Motivation: Breast cancer MRI has high sensitivity but has an unmet need for increased specificity. Sodium MRI has the potential to improve tumor characterisation and thus treatments.

Goal(s): To determine whether there is a relationship between tissue permeability by correlating intracellular sodium fraction with pharmacokinetic parameters.

Approach: Conventional DCE-MRI parameters were acquired as well as intracellular sodium fraction maps (= inversion recovery sodium / total sodium concentration) in 17 breast cancer lesions (grade 1:n=3; grade 2: n=9; grade 3:n=7).

Results: The fraction of intracellular sodium to total sodium concentration had significant correlations (p-values <0.11) with Ktrans and kep, and with cancer grade.

Impact: Breast cancer imaging has an unmet need to differentiate ductal carcinoma from benign and invasive lesions. Sodium MRI can provide intra- and extra-cellular sodium measurements, which may improve lesion differentiation by using endogenous contrast.

1475.
74Quantitative Breast Background Parenchymal Enhancement: Improved Effect Size when Expressed as Contrast Agent Concentration
Henry Rusinek1, Artem Mikheev1, Jean Logan1, Louisa Bokacheva2, and Gean S Kim3
1Radiology, New York University Grossman School of Medicine, New York, NY, United States, 2Neurology, New York University Grossman School of Medicine, New York, NY, United States, 3Radiology, Weil Cornell Medicine, New York, NY, United States

Keywords: Software Tools, Breast, background parenchymal enhancement

Motivation: Background parenchymal enhancement (BPE) is linked to cancer treatment outcomes. Unfortunately field strength, acquisition parameters, etc, influence BPE. More reliable methodology is needed.

Goal(s): We tested a novel BPE measure as contrast concentration to differentiate patient groups. Test1: pathologically complete response after neo-adjuvant therapy vs incomplete response. Test 2: pre- vs post-menopause.

Approach: From a large public imaging archive we randomly selected 32 exams each for Tests 1-2 to compare effect sizes for signal and concentration-based BPE.
 

Results: For both tests, group effects measured using Cohen-d were 2X larger for concentration-based BPE. BPE robustness is improved by converting MR signal to contrast concentration

Impact: Background parenchymal enhancement (BPE) is linked to cancer treatment outcomes. Unfortunately field strength, acquisition parameters, etc, influence conventionally acquired BPE. We propose and validate, using two independent datasets, a more reliable BPE methodology based on quantitative measurement of contrast concentration.

1476.
75Predicting Interstitial Fluid Pressure and Velocity in Breast Cancer with NAC using DCE-MRI and Pharmacokinetic-Fluid Flow Modeling
Arka Bhowmik1, Sunitha Thakur1,2, Olivia Schultz3, Dilip Giri4, Katja Pinker1, and Sarah Eskreis-Winkler1
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States, 2Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, United States, 3Department of Radiology, New York Presbyterian - Weill Cornell Medical Center, New York, NY, United States, 4Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States

Keywords: Breast, Breast

Motivation: Elevated interstitial fluid pressure (IFP) or reduction in velocity (IFV) in breast cancer patients has been shown to contribute to treatment resistance, but its measurement is impractical in clinical practice.

Goal(s): Our goal is to map IFP and IFV from DCE breast MRI and to evaluate its association with treatment response.

Approach: We developed pharmacokinetic-fluid flow models to evaluate its association between IFP, IFV and neoadjuvant chemotherapy (NAC) responses.

Results: We observed small differences in IFP and IVF between NAC treatment cohorts. Initial data based on pre-NAC DCE-breast MRI suggest a potential for early prediction of treatment response of primary tumors.

Impact: Non-invasive pharmacokinetic and computational fluid dynamics modeling in breast DCE-MRI can provide information of tumor IFP and IFV. This approach has the potential to serve as a valuable non-invasive clinical tool for predicting early treatment response.

1477.
76Histogram Analysis of Hepatobiliary Contrast Uptake in Liver Metastases from Pancreatic Ductal Adenocarcinoma for Prognosis Assessment
Nobuyuki Kawai1, Yoshifumi Noda1, Tetsuro Kaga1, Yukiko Takai1, Akio Ito1, Masashi Asano1, Kimihiro Kajita2, and Masayuki Matsuo1
1Radiology, Gifu University, Gifu, Japan, 2Radiology Services, Gifu University Hospital, Gifu, Japan

Keywords: Liver, Liver

Motivation: Liver metastases with contrast uptake on hepatobiliary phase images in patients with pancreatic ductal adenocarcinoma (PDAC) were related to poor prognosis. Prior study focused on visual assessment of the tumor, however, reliable quantitativeness is necessary.

Goal(s): To evaluate the relationship between the gadoxetic acid uptake in liver metastases and overall survival (OS) in patients with PDAC using histogram analysis.

Approach: The best quantitative parameter was analyzed comparable with visual assessment using receiver operating characteristic curve analysis.

Results: Patients with the entropy of >5.422 in the greatest liver metastasis exhibited lower OS rates than those with ≤5.422 (mean, 9.6 months vs 37.7 months).

Impact: Liver metastases with contrast uptake on hepatobiliary phase images were related to poor prognosis. Entropy on histogram features in the greatest liver metastasis can be a potential quantitative imaging biomarker to predict overall survival in patients with pancreatic ductal adenocarcinoma.

1478.
77The clinical value of SWI at 5.0 T ultra‑high field MRI in HCC with Venous System Tumor Thrombosis
Shaopeng Li1, Chuyue Jin2, Kexue Deng1, Yiju XIE1, and Dawei YIN1
1Radiology, The First Affiliated Hospital of USTC(Anhui Provincial Hospital), Hefei, China, 2The First Affiliated Hospital of USTC(Anhui Provincial Hospital), Hefei, China

Keywords: Liver, Cancer

Motivation: Looking for an economical and convenient magnetic resonance imaging technique to detect whether hepatocellular carcinoma is complicated with venous tumor thrombi.

Goal(s): Using a 5.0T ultra-high field MRI imaging sequence to detect the presence of cancer thrombi in HCC patients without the use of contrast agents.

Approach: Statistical analysis of the accuracy of magnetic sensitivity weighted imaging (SWI) in the diagnosis of cancer thrombi using enhanced scanning as the diagnostic criteria.

Results: SWI has high diagnostic accuracy for cancer thrombi without the use of contrast agents.

Impact: Whether HCC with thrombi is crucial for determining clinical treatment plans. Some patients may not be able to use contrast agents, and the cost of contrast agents is high. SWI can effectively display tumor thrombi,  and can reduce patient costs.

1479.
78Mapping 1H MR metabolites to transcriptomics and mass spectrometry imaging in PDAC
Saleem Yousf1, Raj Kumar Sharma1, Balaji Krishnamachary1, Kristine Glunde1,2, Caitlin Tressler1, Michael G Goggins3,4,5, and Zaver Bhujwalla1,2
1Division of Cancer Imaging Research, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, 2Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, 3Departments of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, 4Departments of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, 5Departments of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States

Keywords: Cancer, Cancer, PDAC

Motivation: The poor prognosis of pancreatic ductal adenocarcinoma (PDAC) creates an urgent need to identify new targets. PDAC is a metabolically active cancer that is glutamine avid.

Goal(s): We downregulated the glutamine transporter, SLC1A5, in the patient-derived human cancer cell line, Pa04C, and observed significant tumor growth delay.

Approach: High-field, high-resolution 1H MRS was performed of extracts from wild type, empty vector, and SLC1A5 downregulated tumors that was mapped to transcriptomic analysis of the corresponding cells, and to mass spectrometry imaging (MSI) of human normal and PDAC tissue.

Results: Common pathways were identified from the analysis that identify new targets for PDAC.

Impact: This study contributes to our comprehension of how the glutamate transporter SLC1A5 impacts the transcriptomics of pancreatic cancer cells, influences tumor metabolism, and its connection to variations in human PDAC metabolism. These findings could provide new insights into PDAC cancer.

1480.
79The Preliminary Application of Quantitative Susceptibility Mapping in the T Staging of Rectal Cancer
Haini Zhang1, Yankai Meng1, Lu Han2, and Yongjun Cheng2
1The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China, 2Philips Healthcare, Shanghai, China

Keywords: fMRI Analysis, Cancer

Motivation: The T staging of rectal cancer mainly relies on high-resolution T2-weighted MRI sequences. However, there are cases of both over-staging and under-staging.

Goal(s): To investigate the preliminary application value of quantitative susceptibility mapping in the T staging of rectal cancer.

Approach: In addition to the conventional scanning sequences, horizontal axial T2-weighted imaging (T2WI) and QSM sequences were acquired. The tumor segmentation was done with reference to T2WI images at the QSM-weighted image. The magnetic susceptibility histogram data of tumor tissues were calculated with FireVoxel build 394D software.

Results: The differences of magnetic susceptibility histogram parameters in different T-stage rectal cancer were statistically significant.

Impact: Quantitative susceptibility histogram shows promise in aiding the T staging of rectal cancer.

1481.
80The value of Synthetic Magnetic Resonance Imaging in differentiating Muscular Invasion in Bladder Cancer
Xiaoxian Zhang1, Xuejun Chen1, Chunmiao Xu1, Jinxia Guo2, and You Yun1
1Radiology, Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou, China, 2GE Healthcare MR Research, Beijing, China

Keywords: fMRI Analysis, Bladder

Motivation: The evaluation of muscular invasion in bladder cancer is essential for determining the optimal surgical approach for patients1. The application of Synthetic magnetic resonance imaging (MAGic resonance imaging, MAGiC) in assessing muscular invasion has not been reported previously2.

Goal(s): To assess the value of MAGiC in diagnosing muscular invasion in bladder cancer.

Approach: This study evaluated the differences of T1/T2/ADC and VI-RADS between non-muscle invasive and muscle invasive lesions and the differentiation performance of the indices. 

Results: Improved diagnosis performance was obtained with combined T2 relaxometry and VI-RADS in compared with each single index.

Impact: The findings of this study demonstrate that quantitative MRI parameters enhance the precision and objectivity of assessing muscular invasion in bladder cancer, exhibiting minimal dependence on the clinical experience of diagnostic physician, thus holding promise for their wide-ranging application.